Featured Trials

LS-P-HAT

A Phase 1 Study of NM32-2668 (Anti ROR1/Anti CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors

Status: Open

Trial Type: Breast Cancer, Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer, Melanoma and Skin Cancers, Ovarian Cancer, Soft Tissue and Bone Cancer, Uterine Cancer

Contact: Dr. Benedito Carneiro

Benedito.carneiro@lifespan.org